Clinical Trials Sponsored by Adventia Pharma, S.L.

Total 306 results

Catalysis SL
Atika Pharma S.L.

Recruiting

Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)

Papilloma Viral Infection | CIN1 | LSIL, Low Grade Squamous Intraepithelial Lesion

Spain
Instituto de Investigación Sanitaria de la Fundación...
Biopolis S.L.; Adventia Pharma

Unknown

Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease

Malnutrition | Crohn Disease | Absorption; Disorder | Absorption; Disorder, Protein | Absorption; Disorder, Fat | Absorption; Disorder, Carbohydrate

Spain
Avizorex Pharma, S.L.

Unknown

Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome (AVX012CT001)

Dry Eye Syndrome

Spain
Faes Farma, S.A.
Dynamic Science S.L.

Completed

Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children

Allergic Conjunctivitis

Spain
Faes Farma, S.A.
Dynamic Science S.L.

Terminated

Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids

Haemorrhoids Without Complication

Spain
PT. Innovative Pharma Solutions
Archivel Farma S.L.; RUTI Immunotherapeutics S.L.

Withdrawn

A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)

COVID-19
Mesoestetic Pharma Group S.L.

Completed

Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy

Facial Rejuvenation

Bulgaria
Tedec-Meiji Farma, S.A.
Alpha Bioresearch S.L.

Unknown

Efficacy and Safety of Intraarticular Sodium Hyaluronate Single Injection in Patients With Osteoarthritis of the Knee

Osteoarthritis, Knee

Spain
IDP Discovery Pharma S.L.

Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies (CASSANDRA)

Chronic Lymphocytic Leukemia (CLL) | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Multiple Myeloma (MM) | High Grade B-Cell Lymphoma, Not Otherwise Specified | Double Hit Lymphoma | Triple Hit Lymphoma

Spain
Mesoestetic Pharma Group S.L.

Completed

Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.

Urinary Incontinence | Vaginal Atrophy | Vulvovaginal Signs and Symptoms | Dyspareunia

Bulgaria
Mesoestetic Pharma Group S.L.

Completed

Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic Acid

Wrinkle | Skin Folds

Spain
Mesoestetic Pharma Group S.L.

Completed

Evaluation of the Efficacy and Safety of the Dermal Filler for Augmentation of Labia Majora.

Labia Majora Atrophy and Hypotrophy

Bulgaria
Mesoestetic Pharma Group S.L.

Completed

Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma

Facial Melasma

Spain
UCB Pharma
Pivotal S.L.

Completed

Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine (RETO-PD)

Parkinson's Disease

Spain
Kern Pharma, S.L.
Analysis and Research Network, S.L

Unknown

Clinical Trial to Investigate the Effectiveness of a Dietary Supplement in Increasing Libido and Sexual Function in Postmenopausal Women.

Female Sexual Arousal Disorder

Spain
Aileens Pharma SRL
Advice Pharma Group srl

Recruiting

Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis

Atopic Dermatitis

Italy
Instituto de Investigación Hospital Universitario...
Adventia Pharma

Completed

Study to Evaluate the Organoleptic Perception of Oral Nutritional Supplements for Oncological Patients (SENSORIAL)

Cancer | Malnutrition | Nutrition Related Cancer

Spain
Instituto de Investigación Hospital Universitario...
Adventia Pharma

Completed

Evaluation of the Effect of an Specific Oral Nutritional Supplement on the Nutritional Status in Cancer and Malnutrition

Cancer | Malnutrition | Nutrition Related Cancer

Spain
Endocrinology and Clinical Nutrition Research Center...
Adventia Pharma

Recruiting

Analysis of the Aetiological Factors of Malnutrition (AFEDIN)

Inflammation | Disease-related Malnutrition

Spain
Archivel Farma S.L.

Recruiting

Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis (CONSTAN-ARG)

Tuberculosis, Pulmonary

Argentina
Archivel Farma S.L.

Recruiting

Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)

Tuberculosis, Pulmonary

India
InnoUp Farma S.L.

Unknown

Oral Immunotherapy for Peanut Allergic Patients

Peanut Allergy

Spain
Fundacion Profesor Novoa Santos
ODDS , S.L.; Vifor Pharma España, S.L.

Completed

Feasibility of Implementation of Recommended Standards in Patients With Heart Failure (HFOutcomesSP)

Heart Failure

Spain
Aileens Pharma SRL

Recruiting

Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis

Atopic Dermatitis

Italy
Genesis Pharma S.A.

Completed

Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece (ABReast)

Metastatic Breast Cancer

Greece
Iperboreal Pharma Srl

Completed

Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

Insulin Resistance | End Stage Renal Disease

Italy
Uteron Pharma S.A.

Completed

Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding (LVS-20)

Heavy Menstrual Bleeding
Iperboreal Pharma Srl

Completed

L-Carnitine in Peritoneal Dialysis

End-Stage Renal Disease

Italy
Iperboreal Pharma Srl

Not yet recruiting

Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine

End Stage Renal Disease (ESRD)
Iperboreal Pharma Srl

Recruiting

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. (ELIXIR)

End Stage Renal Disease

Denmark, Sweden, Italy, Spain, United Kingdom, Germany
Iperboreal Pharma Srl

Terminated

Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD

End Stage Renal Disease

Italy
Iperboreal Pharma Srl

Withdrawn

Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

Diabetes | End Stage Renal Disease

Italy
Genesis Pharma S.A.

Completed

A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease (LEGEND)

Relapsed/Refractory Multiple Myeloma

Greece
LaborMed Pharma S.A.

Completed

A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM (AISHA)

Hypertension | Type 2 Diabetes Mellitus

Romania
Palau Pharma S.A.

Completed

Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge

Seasonal Allergic Rhinitis

Germany
Palau Pharma S.A.

Completed

A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Belgium, Hungary, Slovakia, Spain
Addex Pharma S.A.

Terminated

ADX10059 Migraine Prevention Study

Migraine

Germany, Austria, Belgium, France, United Kingdom
Addex Pharma S.A.

Recruiting

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Parkinson Disease | Dyskinesias | Dyskinesia, Drug-Induced

United States
Addex Pharma S.A.

Recruiting

Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm

Dystonia | Blepharospasm

United States
Addex Pharma S.A.

Recruiting

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Parkinson Disease | Dyskinesias | Dyskinesia, Drug-Induced

United States
Iperboreal Pharma Srl

Not yet recruiting

Peritoneal Ultrafiltration in Cardio Renal Syndrome. (PURE)

Congestive Heart Failure

Italy
Genesis Pharma S.A.

Completed

Retrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Life Conditions (POWERFUL)

Relapse/Refractory Multiple Myeloma

Greece
Genesis Pharma S.A.

Completed

A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece (beYOND-STS)

Advanced Soft Tissue Sarcoma

Greece
Iperboreal Pharma Srl

Withdrawn

Study of Safety and Efficacy on New Peritoneal Dialysis Solutions

End-Stage Renal Disease
Iperboreal Pharma Srl

Completed

L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis

End-Stage Renal Disease

Italy
Addex Pharma S.A.

Completed

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

Parkinson's Disease

United States, Austria, France, Germany
Addex Pharma S.A.

Completed

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

Gastroesophageal Reflux

United States, France, Germany, Netherlands, Switzerland
Addex Pharma S.A.

Completed

ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)

Gastroesophageal Reflux

Austria, Belgium, France, Germany
Grupo Español Multidisciplinar de Melanoma
Roche Farma, S.A; Pivotal S.L.

Completed

Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma

Melanoma

Spain
Fundación Pública Andaluza para la Investigación...
Adventia Pharma

Completed

Efficacy of Two ONS in Patients at Nutritional Risk With Type 2 Diabetes Mellitus (DIACARE)

Malnutrition | Type 2 Diabetes

Spain

3

Subscribe